Intravenous fosfomycin in patients with liver disease for extensively drug-resistant Gram-negative bacteria - 11/08/18
Doi : 10.1016/j.jinf.2018.07.013
Athina Pyrpasopoulou a, b, Georgia Pitsava a, c, Elias Iosifidis a, c, George Imvrios d, Eleni Massa e, Eleni Mouloudi e, Ioannis Goulis f, Eleni Chatzidrosou g, Charalampos Antachopoulos a, c, Ioannis Fouzas d, Emmanuel Roilides a, c, ⁎ 
a Infectious Diseases Unit, Hippokration General Hospital, Thessaloniki Greece
b 2nd Propedeutic Department of Internal Medicine, Medical Faculty, Aristotle University School of Health Sciences, Hippokration Hospital, Thessaloniki, Greece
c 3rd Department of Pediatrics, Medical Faculty, Aristotle University School of Health Sciences, Hippokration Hospital, Thessaloniki, Greece
d Solid Organ Transplantation Department, Medical Faculty, Aristotle University School of Health Sciences, Hippokration General Hospital, Thessaloniki Greece
e Intensive Care Unit, Hippokration General Hospital, Thessaloniki Greece
f 4th Department of Internal Medicine, Medical Faculty, Aristotle University School of Health Sciences, Hippokration General Hospital, Thessaloniki Greece
g Microbiology Department, Hippokration General Hospital, Thessaloniki Greece
⁎Corresponding author.
Sous presse. Épreuves corrigées par l'auteur.
Disponible en ligne depuis le Saturday 11 August 2018
Le texte complet de cet article est disponible en PDF.
© 2018
The British Infection Association. Publié par Elsevier Masson SAS. Tous droits réservés.
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?